Estimated antiretroviral therapy coverage among people living with HIV in Netherlands
Netherlands: Estimated antiretroviral therapy coverage among people living with HIV was 89.0% in 2024. ▲ Rising
Estimated antiretroviral therapy coverage among people living with HIV in Netherlands, 2000–2024
Source: World Health Organization, Global Health Observatory.
Analysis
Netherlands recorded 89.0% for estimated antiretroviral therapy coverage among people living with hiv in 2024. That is the highest value across all 25 years on record.
That represents a change of up 1.1% on the previous year and up 15.6% over ten years.
Over the whole period, estimated antiretroviral therapy coverage among people living with hiv in Netherlands peaked at 89.0% in 2024 and was at its lowest, 46.0%, in 2000.
That places Netherlands 22nd out of 143 countries with data for 2024, putting it in the top quarter.
The long-run direction has been consistently rising across the 25 years of available data.
Estimated antiretroviral therapy coverage among people living with HIV in Netherlands, year by year
| Year | Value | Change |
|---|---|---|
| 2000 | 46.0% | — |
| 2001 | 49.0% | +6.5% |
| 2002 | 51.0% | +4.1% |
| 2003 | 52.0% | +2.0% |
| 2004 | 53.0% | +1.9% |
| 2005 | 53.0% | +0.0% |
| 2006 | 54.0% | +1.9% |
| 2007 | 56.0% | +3.7% |
| 2008 | 59.0% | +5.4% |
| 2009 | 62.0% | +5.1% |
| 2010 | 65.0% | +4.8% |
| 2011 | 67.0% | +3.1% |
| 2012 | 70.0% | +4.5% |
| 2013 | 74.0% | +5.7% |
| 2014 | 77.0% | +4.1% |
| 2015 | 80.0% | +3.9% |
| 2016 | 82.0% | +2.5% |
| 2017 | 84.0% | +2.4% |
| 2018 | 85.0% | +1.2% |
| 2019 | 87.0% | +2.4% |
| 2020 | 87.0% | +0.0% |
| 2021 | 87.0% | +0.0% |
| 2022 | 88.0% | +1.1% |
| 2023 | 88.0% | +0.0% |
| 2024 | 89.0% | +1.1% |
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 2000s | 53.5% | 46.0% | 62.0% | 10 |
| 2010s | 77.1% | 65.0% | 87.0% | 10 |
| 2020s | 87.8% | 87.0% | 89.0% | 5 |
Countries ranked near Netherlands
More health data for Netherlands
- Un projection of annual infant deaths, annual growth rate -2.44 % change on previous year (2100)
- Heat deaths vs projected death rates, annual growth rate 0.1866 % change on previous year (2090)
- Estimated changes in temperature-related death rates compared to projected death rates 1,235 deaths per 1,000 people (2090)
- Number of infants who die before age 1 80 deaths (2100)
- Population ages 15-19, male, annual growth rate -0.3898 % change on previous year (2025)
- Population ages 15-19, male, per unit of GDP 0 units per US$ of GDP (2025)
- Population ages 15-19, male, per capita 0.0282 units per person (2025)
- Population ages 20-24, female, annual growth rate -0.7121 % change on previous year (2025)
- Population ages 20-24, female, per unit of GDP 0 units per US$ of GDP (2025)
- Population ages 20-24, female, per capita 0.0315 units per person (2025)
Frequently asked questions
- What is estimated antiretroviral therapy coverage among people living with hiv in Netherlands?
- Estimated antiretroviral therapy coverage among people living with hiv in Netherlands was 89.0% in 2024, according to World Health Organization, Global Health Observatory.
- What is the highest estimated antiretroviral therapy coverage among people living with hiv recorded in Netherlands?
- The highest recorded value was 89.0% in 2024.
- What is the lowest estimated antiretroviral therapy coverage among people living with hiv recorded in Netherlands?
- The lowest recorded value was 46.0% in 2000.
- How does Netherlands rank for estimated antiretroviral therapy coverage among people living with hiv?
- Netherlands ranks 22nd out of 143 countries with data for 2024.
- Is estimated antiretroviral therapy coverage among people living with hiv rising or falling in Netherlands?
- Over the last ten years it is up 15.6%. The long-run trend across the full record is rising.
- Where does this Netherlands data come from?
- The figures come from World Health Organization, Global Health Observatory, published as part of Estimated antiretroviral therapy coverage among people living with HIV (%). Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 25 observations, free to reuse under CC BY-NC-SA 3.0 IGO (WHO).